CRISPR gene editing technology put to its first clinical test in cancer trial
If all goes according to plan, this August will mark the start of the first clinical trial using cells that have had their genes edited by CRISPR technology. Sichuan University’s West China Hospital has recently been granted permission to begin using the therapy in people with lung cancer1, while earlier in the year a US [Read More]